Healthy volunteers help test how common meds change AP31969 levels
NCT ID NCT07449390
First seen Mar 18, 2026 · Last updated Jun 18, 2026 · Updated 15 times
Summary
This study looked at how two common drugs—carbamazepine (a strong inducer) and itraconazole (a strong inhibitor)—affect the levels of a single dose of AP31969 in the blood of 28 healthy adults. The goal was to understand how these interactions might change the drug's breakdown, which helps guide safe dosing in future studies. Participants took AP31969 alone and then with each other drug to compare the effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON Early Phase Services, LLC
San Antonio, Texas, 78232, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.